RARE - Ultragenyx Pharmaceutical GAAP EPS of -$1.52 beats by $0.10 revenue of $127.39M beats by $5.34M
2024-02-15 16:02:14 ET
More on Ultragenyx Pharmaceutical
- A Deeper Look At Ultragenyx Pharmaceutical
- DOJ says Ultragenyx to pay $6M to resolve Medicare claims allegations
- Wells Fargo starts Ultragenyx coverage with overweight rating
- Seeking Alpha’s Quant Rating on Ultragenyx Pharmaceutical
- Historical earnings data for Ultragenyx Pharmaceutical